Time will be on our side now.Ok so over the next couple months they are going to work with the FDA to find out exactly what they need to do for another P3 trial. They are now willing to sell the drug or company or partner up with a us drug comp to do this. What kind of offers do you think they will get. Selling the company would defiantly get them cash value. Selling the drug would also get them some quick cash. Partnering with a US comp would probably get them there best long term value?
Anyone have any thoughts on this.